2021
Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States
Simoni MK, Gilstad-Hayden K, Naqvi SH, Pal L, Yonkers KA. Progression of depression and anxiety symptoms in pregnancies conceived by assisted reproductive technology in the United States. Journal Of Psychosomatic Obstetrics & Gynecology 2021, 43: 214-223. PMID: 34472405, PMCID: PMC10116357, DOI: 10.1080/0167482x.2021.1971193.Peer-Reviewed Original ResearchMeSH KeywordsAnxietyDepressionFemaleHumansPregnancyProspective StudiesPsychiatric Status Rating ScalesReproductive Techniques, AssistedUnited StatesConceptsAssisted-reproductive technologyEdinburgh Postnatal Depression ScalePlanned pregnanciesPostnatal Depression ScaleGestational time periodsART pregnanciesProspective cohortPregnant womenWeeks postpartumGeneralized Estimating EquationsObstetrical practiceDepression ScaleDepressive symptomsPregnancyBlue studiesSecondary analysisConception groupMental healthAnxiety subscaleAnxiety symptomsWomenGroup changesSymptomsPrevalenceWeeks
2019
Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta‐analysis
Levis B, McMillan D, Sun Y, He C, Rice DB, Krishnan A, Wu Y, Azar M, Sanchez TA, Chiovitti MJ, Bhandari PM, Neupane D, Saadat N, Riehm KE, Imran M, Boruff JT, Cuijpers P, Gilbody S, Ioannidis JPA, Kloda LA, Patten SB, Shrier I, Ziegelstein RC, Comeau L, Mitchell ND, Tonelli M, Vigod SN, Aceti F, Alvarado R, Alvarado‐Esquivel C, Bakare MO, Barnes J, Beck CT, Bindt C, Boyce PM, Bunevicius A, Castro e Couto T, Chaudron LH, Correa H, de Figueiredo F, Eapen V, Fernandes M, Figueiredo B, Fisher JRW, Garcia‐Esteve L, Giardinelli L, Helle N, Howard LM, Khalifa DS, Kohlhoff J, Kusminskas L, Kozinszky Z, Lelli L, Leonardou AA, Lewis BA, Maes M, Meuti V, Radoš S, García P, Nishi D, E‐Andjafono D, Robertson‐Blackmore E, Rochat TJ, Rowe HJ, Siu BWM, Skalkidou A, Stein A, Stewart RC, Su K, Sundström‐Poromaa I, Tadinac M, Tandon SD, Tendais I, Thiagayson P, Töreki A, Torres‐Giménez A, Tran TD, Trevillion K, Turner K, Vega‐Dienstmaier J, Wynter K, Yonkers KA, Benedetti A, Thombs BD. Comparison of major depression diagnostic classification probability using the SCID, CIDI, and MINI diagnostic interviews among women in pregnancy or postpartum: An individual participant data meta‐analysis. International Journal Of Methods In Psychiatric Research 2019, 28: e1803. PMID: 31568624, PMCID: PMC7027670, DOI: 10.1002/mpr.1803.Peer-Reviewed Original ResearchMeSH KeywordsAdultDepression, PostpartumDepressive Disorder, MajorFemaleHumansInterview, PsychologicalPregnancyPregnancy ComplicationsPsychiatric Status Rating ScalesConceptsComposite International Diagnostic InterviewEdinburgh Postnatal Depression ScaleIndividual participant dataDiagnostic InterviewEPDS scoresPatient Health Questionnaire-9Mini International Neuropsychiatric InterviewParticipant dataDifferent diagnostic interviewsPostnatal Depression ScaleInternational Neuropsychiatric InterviewStructured Clinical InterviewPrevious individual participant dataMINI diagnostic interviewQuestionnaire-9Neuropsychiatric InterviewMajor depressionDepression ScaleDepressive symptomsClinical InterviewParticipant characteristicsLinear mixed modelsPregnancyPostpartumSCID
2013
Perinatal smoking and depression in women with concurrent substance use
Forray A, Gotman N, Kershaw T, Yonkers KA. Perinatal smoking and depression in women with concurrent substance use. Addictive Behaviors 2013, 39: 749-756. PMID: 24447885, PMCID: PMC3944019, DOI: 10.1016/j.addbeh.2013.12.008.Peer-Reviewed Original ResearchConceptsPregnant womenConcurrent substance useSubstance usePre-pregnancy smokersSignificant depressive symptomsWeeks of pregnancyMini Neuropsychiatric InterviewDiagnosis of depressionImpact of depressionCourse of smokingNon-depressed groupLinear mixed effects regressionSubstance abuse treatmentPerinatal smokingSmoking postpartumBaseline cohortNeuropsychiatric InterviewMixed effects regressionDepressive symptomsSmokingSmoking behaviorDepressive symptomatologyAbuse treatmentPregnancyPostpartum
2011
Does Antidepressant Use Attenuate the Risk of a Major Depressive Episode in Pregnancy?
Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL, Lin H, Burkman RT, Zelop CM, Lockwood CJ. Does Antidepressant Use Attenuate the Risk of a Major Depressive Episode in Pregnancy? Epidemiology 2011, 22: 848-854. PMID: 21900825, PMCID: PMC3188383, DOI: 10.1097/ede.0b013e3182306847.Peer-Reviewed Original ResearchConceptsMajor depressive episodeDepressive episodeAntidepressant useDepressive disorderHigh riskNew major depressive episodesComposite International Diagnostic InterviewDiscontinuation of antidepressantsMajor depressive disorderTime-dependent predictorsAntidepressant medicationAntidepressant treatmentRecurrent illnessAntidepressant discontinuationCox regressionPostpartum womenBlack raceMore episodesObstetrical settingHispanic ethnicityHispanic womenNew episodesPregnancyDiagnostic InterviewAntidepressants
2003
Premenstrual disorders: bridging research and clinical reality
Yonkers KA, Pearlstein T, Rosenheck RA. Premenstrual disorders: bridging research and clinical reality. Archives Of Women's Mental Health 2003, 6: 287-292. PMID: 14628181, DOI: 10.1007/s00737-003-0026-4.Peer-Reviewed Original ResearchMeSH KeywordsAdultConnecticutDepressive DisorderDiagnostic and Statistical Manual of Mental DisordersFemaleHumansPatient Acceptance of Health CarePatient SelectionPremenstrual SyndromePsychiatric Status Rating ScalesSelective Serotonin Reuptake InhibitorsSelf-AssessmentSeverity of Illness IndexSurveys and QuestionnairesTreatment OutcomeConceptsPremenstrual dysphoric disorderPremenstrual symptomsTreatment resultsBrief Patient Health QuestionnaireConcurrent psychiatric conditionsOb-gyn settingsStatistical Manual IV criteriaSerotonin reuptake inhibitorsUsual care settingsPatient Health QuestionnaireMinor depressive disorderActual clinical practiceTypes of symptomsEligible womenPatient characteristicsReuptake inhibitorsOpen trialSymptomatic subgroupCurrent comorbidityIV criteriaClinical trialsDepressive disorderHealth QuestionnaireTypical patientDysphoric disorder
2001
Onset and Persistence of Postpartum Depression in an Inner-City Maternal Health Clinic System
Yonkers KA, Ramin SM, Rush AJ, Navarrete CA, Carmody T, March D, Heartwell SF, Leveno KJ. Onset and Persistence of Postpartum Depression in an Inner-City Maternal Health Clinic System. American Journal Of Psychiatry 2001, 158: 1856-1863. PMID: 11691692, DOI: 10.1176/appi.ajp.158.11.1856.Peer-Reviewed Original ResearchConceptsMajor depressive disorderDepressive disorderPostpartum womenPostpartum periodCaucasian womenPostpartum depressionDepressive symptomsDisturbed mother-infant relationshipsPostpartum major depressive disorderEdinburgh Postnatal Depression ScaleMaternal Health ClinicPersistent depressive symptomsFirst postpartum visitPostnatal Depression ScalePostpartum depressive disordersStructured Clinical InterviewMother-infant relationshipPostpartum visitPregnant womenClinic populationNonpostpartum womenMaternal disabilityMultistage screening processHealth clinicsDepressed womenVenlafaxine in the treatment of premenstrual dysphoric disorder.
Freeman E, Rickels K, Yonkers K, Kunz N, McPherson M, Upton G. Venlafaxine in the treatment of premenstrual dysphoric disorder. Obstetrics And Gynecology 2001, 98: 737-44. PMID: 11704162, DOI: 10.1016/s0029-7844(01)01530-7.Peer-Reviewed Original ResearchMeSH KeywordsAdultCyclohexanolsDouble-Blind MethodFemaleHumansPremenstrual SyndromePsychiatric Status Rating ScalesSelective Serotonin Reuptake InhibitorsVenlafaxine HydrochlorideConceptsPremenstrual dysphoric disorderDaily symptom reportsTreatment of premenstrual dysphoric disorderDysphoric disorderHamilton Rating Scale for DepressionPremenstrual dysphoric disorder treatmentDSR scoresEfficacy of long-term maintenance treatmentSafety of venlafaxineFlexible-dose trialNew-generation antidepressantsLong-term maintenance treatmentDouble-blind treatmentTreatment cyclesPremenstrual symptom scoresVenlafaxine doseVenlafaxine treatmentSymptom reductionSymptom remissionInhibit serotoninNorepinephrine reuptakePMDD symptomsVenlafaxineSymptom reportingCyclic disorderAn Eight-Year Longitudinal Comparison of Clinical Course and Characteristics of Social Phobia Among Men and Women
Yonkers KA, Dyck IR, Keller MB. An Eight-Year Longitudinal Comparison of Clinical Course and Characteristics of Social Phobia Among Men and Women. Psychiatric Services 2001, 52: 637-643. PMID: 11331798, DOI: 10.1176/appi.ps.52.5.637.Peer-Reviewed Original ResearchConceptsHealth-related qualityHarvard/Brown Anxiety Research ProgramSuicide attemptsSocial phobiaComorbid substance use disorderPoorer baseline functioningLower Global AssessmentPercent of menPercent of womenSubstance use disordersPotential sex differencesComplete remissionRemission rateClinical courseChronic courseEight-year study periodChronic disordersHigh prevalenceObservational studyFunctioning scoresUse disordersBaseline functioningConcurrent agoraphobiaGreater chronicityGlobal assessment